Bupropion

Sep 27, 2019

Currax(TM) Pharmaceuticals LLC Announces the Acquisition of Nalpropion Pharmaceuticals, Inc.

Jan 04, 2019

S1 Biopharma Announces Expanded Analysis of Phase 2a Data on Lorexys(TM) for Treatment of Hypoactive Sexual Desire Disorder Based on PGIC Scale to be Presented at 2019 ISSWSH/ISSM Joint Meeting

Mar 12, 2018

Orexigen Therapeutics, Inc. Plans For Near-term Sale Using Structured Process Through Chapter 11 Of U.S. Bankruptcy Code

Nov 13, 2017

Orexigen Therapeutics Announces Commercialization and Distributorship Agreement with Merck KGaA, Darmstadt, Germany for Contrave in Latin America

Nov 13, 2017

Orexigen Therapeutics Announces Third Quarter 2017 Financial Results

Aug 10, 2017

International Laboratories, LLC Issues Voluntary Nationwide Recall of one (1) Lot of Pravastatin Sodium Tablets USP, 40 mg packaged in bottles of 30 tablets Due to Mislabeling

Aug 07, 2017

Orexigen Therapeutics Announces Commercialization and Distributorship Arrangement with Cheplapharm Arzneimittel GmbH for Mysimba(TM) in Germany, France and Austria

Jul 26, 2017

Orexigen Therapeutics Announces Expansion of Distributorship Agreement with Biologix FZCO for Contrave® (naltrexone HCl / bupropion HCl extended release) to Egypt